These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 2462882)

  • 41. Development of an LC-MS/MS assay for the quantitative determination of the intracellular 5-fluorouracil nucleotides responsible for the anticancer effect of 5-fluorouracil.
    Derissen EJ; Hillebrand MJ; Rosing H; Schellens JH; Beijnen JH
    J Pharm Biomed Anal; 2015 Jun; 110():58-66. PubMed ID: 25804433
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Biochemical determinants of responsiveness to 5-fluorouracil and its derivatives in xenografts of human colorectal adenocarcinomas in mice.
    Houghton JA; Maroda SJ; Phillips JO; Houghton PJ
    Cancer Res; 1981 Jan; 41(1):144-9. PubMed ID: 7448754
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Potentiation of quinazoline antifolate (CB3717) toxicity by dipyridamole in human lung carcinoma, A549, cells.
    Curtin NJ; Harris AL
    Biochem Pharmacol; 1988 Jun; 37(11):2113-20. PubMed ID: 3377815
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Sequential methotrexate/5-FU: FdUMP formation and TS inhibition in a transplantable rodent colon adenocarcinoma.
    Berne MH; Gustavsson BG; Almersjö O; Spears PC; Frösing R
    Cancer Chemother Pharmacol; 1986; 16(3):237-42. PubMed ID: 3698165
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Modulation of 5-fluorouracil toxicity by uridine, deoxyuridine, orotate and dipyridamole in normal tissues of rats with liver adenocarcinoma.
    el Hag IA; Jakobsson B; Christensson PI; Erichsen C; Jönsson PE; Stenram U
    In Vivo; 1987; 1(5):309-12. PubMed ID: 2485133
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Development, characterization and application of an antibody against 5-fluoro-2'deoxyuridine-5'monophosphate, the active metabolite of 5-fluorouracil.
    Peters GJ; Laurensse E; Steinbusch HW; De Vente J; Smid K; Van der Wilt CL; Pinedo HM
    Anticancer Res; 1993; 13(4):835-9. PubMed ID: 8352551
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Azidothymidine and dipyridamole as biochemical response modifiers: synergism with methotrexate and 5-fluorouracil in human colon and pancreatic carcinoma cells.
    Zhen YS; Taniki T; Weber G
    Oncol Res; 1992; 4(2):73-8. PubMed ID: 1596584
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Azidothymidine-induced cytotoxicity and incorporation into DNA in the human colon tumor cell line HCT-8 is enhanced by methotrexate in vitro and in vivo.
    Tosi P; Calabresi P; Goulette FA; Renaud CA; Darnowski JW
    Cancer Res; 1992 Aug; 52(15):4069-73. PubMed ID: 1638518
    [TBL] [Abstract][Full Text] [Related]  

  • 49. 5-Ethoxy-2'-deoxyuridine, a novel substrate for thymidine phosphorylase, potentiates the antitumor activity of 5-fluorouracil when used in combination with interferon, an inducer of thymidine phosphorylase expression.
    Schwartz EL; Baptiste N; Megati S; Wadler S; Otter BA
    Cancer Res; 1995 Aug; 55(16):3543-50. PubMed ID: 7627962
    [TBL] [Abstract][Full Text] [Related]  

  • 50. 5-Fluorouracil enhances azidothymidine cytotoxicity: in vitro, in vivo, and biochemical studies.
    Brunetti I; Falcone A; Calabresi P; Goulette FA; Darnowski JW
    Cancer Res; 1990 Jul; 50(13):4026-31. PubMed ID: 2354452
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Modulation of 1-beta-D-arabinofuranosylcytosine metabolism and cytotoxicity in L1210 cells by fluoropyrimidine pretreatment.
    Grant S; Cadman E
    Cancer Res; 1982 Sep; 42(9):3550-6. PubMed ID: 6213294
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Aberrant cell cycle inhibition pattern in human colon carcinoma cell lines after exposure to 5-fluorouracil.
    Pizzorno G; Sun Z; Handschumacher RE
    Biochem Pharmacol; 1995 Feb; 49(4):553-7. PubMed ID: 7872961
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Sequence-dependent interaction of 5-fluorouracil and arabinosyl-5-azacytosine or 1-beta-D-arabinofuranosylcytosine.
    Grem JL; Allegra CJ
    Biochem Pharmacol; 1991 Jul; 42(2):409-18. PubMed ID: 1713459
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Interferon effects upon fluorouracil metabolism by HL-60 cells.
    Elias L; Sandoval JM
    Biochem Biophys Res Commun; 1989 Sep; 163(2):867-74. PubMed ID: 2783128
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Novel mechanism(s) of resistance to 5-fluorouracil in human colon cancer (HCT-8) sublines following exposure to two different clinically relevant dose schedules.
    Aschele C; Sobrero A; Faderan MA; Bertino JR
    Cancer Res; 1992 Apr; 52(7):1855-64. PubMed ID: 1532346
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Modulation of the biochemical effect of 5-fluorouracil (5-FU) by leucovorin measured by thymidylate synthase activity and nucleoside incorporation into DNA].
    Kau B; Rieger M; Sauer H
    Onkologie; 1990 Dec; 13(6):453-7. PubMed ID: 2092282
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Improved measurement of thymidylate synthetase activity by a modified tritium-release assay.
    Armstrong RD; Diasio RB
    J Biochem Biophys Methods; 1982 Jun; 6(2):141-7. PubMed ID: 7108126
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cellular pharmacology of 5-fluorouracil in a human colon adenocarcinoma cell line selected for thymidine kinase deficiency.
    Radparvar S; Houghton PJ; Germain G; Pennington J; Rahman A; Houghton JA
    Biochem Pharmacol; 1990 Jun; 39(11):1759-65. PubMed ID: 2344373
    [TBL] [Abstract][Full Text] [Related]  

  • 59. 5-ethyl-2'-deoxyuridine, a modulator of both antitumour action and pharmacokinetics of 5-fluorouracil.
    Kralovánszky J; Katona C; Jeney A; Pandi E; Noordhuis P; Erdélyi-Tóth V; Otvös L; Kovács P; Van der Wilt CL; Peters GJ
    J Cancer Res Clin Oncol; 1999 Dec; 125(12):675-84. PubMed ID: 10592100
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Mechanisms of resistance to fluoropyrimidines.
    Zhang ZG; Harstrick A; Rustum YM
    Semin Oncol; 1992 Apr; 19(2 Suppl 3):4-9. PubMed ID: 1532673
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.